Current Opinion in Virology was launched to provide a systematic.

Elsevier launches Current Opinion in virologyElsevier publication of the first edition of Current Opinion in Virology publish a new magazine in its prestigious Current Opinion series has announced six issues per year. Current Opinion in Virology was launched to provide a systematic, comprehensive and filtered approach to the ever-growing wealth of research on viruses and viral interaction published: a platform to help professionals professionals up-to-date deals with the latest trends and themes research in virology. The journal publishes invited review articles only and is divided into twelve annual sections, including viral genomics, antivirals and resistance, emerging viruses and virus evolution.

Has the vaccine can cause disease , despite very modest financial support, it recently failed to achieve a major breakthrough in understanding ,, results were presented at the ENS Meeting in Prague, We know there must be a genetic factor as well as nearly all narcolepsy patients share a certain amount of blood factors in their leukocytes. Although this can be found in a develops only develops only one in 500 of the disease. So it must be, said Professor Bassetti, be additional factors onset of disease onset of the disease in those who develop a genetic predisposition for it.Agreement for pregnant women no alternative treatments, 'FDA and Pfizer, 100.000 people benefit ratio remains 'advantageous for permitting the use of Viracept is, in his letter (Reuters.. Yahoo! possible carcinogen warned antiretroviral treatment Viracept.

Tests have a 'potential human carcinogen 'recognize in lots of antiretrovirals Viracept is Pfizer announced the FDA and pharmaceutical companies Monday, Reuters news agency reports. Pfizer a letter to healthcare professionals in that the chemical ethyl methane sulfonate - or EMS the will be formed during production - been shown to cause cancer and birth defects in animals, but no human data are available .

Pfizer said it was together with the FDA in order to immediate and long-term processes to EMS layers deep (AP ,, According to the company EMS ' 'markedly lower 'than those that invited Roche in June, says every batches of Viracept of Europe and other countries, reminiscent, the Reuters news agency. 'Pfizer is with the FDA together to prospectively restrict EMS planes in Viracept while taking due account the direct needs of up of patients, 'the company in a statement.